| 产品名称 | XMD 8-92 |
| 产品货号 | Axon 1846 CAS [1234480-50-2] MF C26H30N6O3MW 474.55 Purity: 99% Soluble in DMSO Description Potent and selective inhibitor of big MAP kinase 1 (BMK1/ERK5). Note: XMD 8-92 is also available as water soluble TFA-salt (Axon 1621) References Certificates Categories Extra info Q. Yang et al. Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein. Cancer Cell, 2010, 18(3), 258-267. Q Yang and JD Lee. Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy. Clin. Cancer Res. 2011, 17, 3527-3532. BA Drew, ME Burowa , BS Beckman. MEK5/ERK5 pathway: The first fifteen years. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012, 1825 (1), 37-48. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology MAPK EC 2.7.11.24 ERK BMK1 inhibitor; ERK5 inhibitor Chemical name 2-(2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenylamino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one Source information Sold under agreement with the Dana-Faber Cancer Institute Parent CAS No. [1234480-50-2] Order Size Unit Price Stock 2 mg €70.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
XMD 8-92Axon 1846 CAS [1234480-50-2] MF C26H30N6O3
DescriptionPotent and selective inhibitor of big MAP kinase 1 (BMK1/ERK5). Note: XMD 8-92 is also available as water soluble TFA-salt (Axon 1621)
BMK1 inhibitor; ERK5 inhibitor
Chemical name2-(2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenylamino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one Source informationSold under agreement with the Dana-Faber Cancer InstituteParent CAS No.[1234480-50-2] |
| 产品资料 |
